Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ASSERTIO

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 25
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

CIPLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 22
  • 0 comments

FDA approve EMTRICITABINE

Comment Full text

HORIZON

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 26
  • 0 comments

FDA approve FAMOTIDINE; IBUPROFEN

Comment Full text

AVONDALE PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 27
  • 0 comments

FDA approve MELOXICAM

Comment Full text

CUMBERLAND PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 22
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

ICEUTICA OPERATIONS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 27
  • 0 comments

FDA approve MELOXICAM

Comment Full text

UPJOHN

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 23
  • 0 comments

FDA approve CELECOXIB

Comment Full text

SCILEX PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 22
  • 0 comments

FDA approve CELECOXIB

Comment Full text

MYLAN LABS LTD

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 23
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

CURRAX

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 25
  • 0 comments

FDA approve NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

Comment Full text
  • Previous
  • 212
  • 213
  • 214
  • 215
  • 216
  • Next

Search

News categories

  • Technical Exchange News(9910)
  • Event(410)
  • SEC News(167597)
  • FDA Approval(9356)
  • Company Report(721)
  • Business News(111445)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin